| CTRI Number |
CTRI/2026/03/105172 [Registered on: 02/03/2026] Trial Registered Prospectively |
| Last Modified On: |
28/02/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
A Study to Compare the Effect of Anandbhairavi Vati and Varunadi Kashaya in the Treatment of Urinary Stones |
|
Scientific Title of Study
|
A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF ANANDBHAIRAVI VATI & VARUNADI KASHAYA IN THE MANAGEMENT OF MUTRASHMARI W.S.R TO UROLITHIASIS |
| Trial Acronym |
STONE-AYU |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Najeeb TK |
| Designation |
Professor |
| Affiliation |
Shri Babu SIngh Jay Singh Ayurvedic Medical College And Hospital Farrukhabad |
| Address |
Doctors Residence Department of PG Studies in Shalya Tantra Shri Babu Singh Jay Singh Ayurvedic Medical College Farrukhabad Uttar Pradesh 209602
Farrukhabad UTTAR PRADESH 209602 India |
| Phone |
9947873825 |
| Fax |
|
| Email |
drnajeebtk@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Najeeb TK |
| Designation |
Professor |
| Affiliation |
Shri Babu SIngh Jay Singh Ayurvedic Medical College And Hospital Farrukhabad |
| Address |
Doctors Residence Department of PG Studies in Shalya Tantra Shri Babu Singh Jay Singh Ayurvedic Medical College Farrukhabad Uttar Pradesh 209602
Farrukhabad UTTAR PRADESH 209602 India |
| Phone |
9947873825 |
| Fax |
|
| Email |
drnajeebtk@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Najeeb TK |
| Designation |
Professor |
| Affiliation |
Shri Babu SIngh Jay Singh Ayurvedic Medical College And Hospital Farrukhabad |
| Address |
Doctors Residence Department of PG Studies in Shalya Tantra Shri Babu Singh Jay Singh Ayurvedic Medical College Farrukhabad Uttar Pradesh 209602
Farrukhabad UTTAR PRADESH 209602 India |
| Phone |
9947873825 |
| Fax |
|
| Email |
drnajeebtk@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Self |
| Address |
Shri Babu Singh Jay Singh Ayurvedic Medical College And Hospital Farrukhabad Uttar Pradesh |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR ARUN KUMAR |
SHRI BABU SINGH JAY SINGH AYURVEDIC MEDICAL COLLEGE AND HOSPITAL FARRUKHABAD UTTAR PRADESH |
Department of Shalya Tantra second floor Room No 215 Farrukhabad UTTAR PRADESH |
8057270644
arunkushwaha622@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N200||Calculus of kidney. Ayurveda Condition: MUTRAVAHASROTOVIKARAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Anandbhairavi Vati, Reference: Brihad Nighantu Ratnakar, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Ushna jala ), Additional Information: -(2) Medicine Name: Varunadi Kashaya , Reference: Sharangdhar Samhita, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Ushna Jala), Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
16.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients with specific Lakshanas of Mutrashmari will be included in the present study.
The patients between the age group of 16-60 years will be selected irrespective of sex, occupation, race, chronicity and socio- economic status.
Patient having Calculi measuring up to 10 mm will be included for the present study.
|
|
| ExclusionCriteria |
| Details |
Patients who are suffering with severe systemic disorders like renal failure, tuberculosis, congenital disorders and neoplasm will be excluded.
Acute urinary obstructive conditions will be excluded.
When stone is obstructed in the natural constrictions of the ureter.
|
|
|
Method of Generating Random Sequence
|
Stratified randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Reduction in size of urinary calculus (USG / X-ray KUB) |
30 DAYS |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Reduction in severity of Mutrashmari symptoms (pain, dysuria, frequency of micturition) |
Baseline, Day 15, and Day 30 |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
15/03/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
15/03/2026 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="8" Days="30" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Mutrashmari (urolithiasis) is a common urinary disorder characterized by the formation of calculi in the urinary tract, leading to pain, dysuria, and other urinary symptoms. Ayurveda describes Mutrashmari as one of the Ashta Mahagada. Anandbhairavi Vati and Varunadi Kashaya are classical Ayurvedic formulations indicated in the management of Mutrashmari. The present study is planned to evaluate and compare the efficacy of Anandbhairavi Vati and Varunadi Kashaya in the management of Mutrashmari with special reference to urolithiasis. This will be an interventional, randomized, open-label, parallel-group, active-controlled clinical trial conducted on patients diagnosed with urolithiasis. The outcome will be assessed based on reduction in size of urinary calculus and improvement in clinical symptoms. |